Latest News

• share
• favorite_border

In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have shown that breast cancer patients who participate in a yoga program during treatment have improved quality of life, compared to patients who do not.

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center have received a $2.4 million grant from the National Cancer Institute to study the effects of Tibetan yoga in women with breast cancer who are undergoing chemotherapy.

• share
• favorite_border

Brain tumor specialists at The University of Texas M. D. Anderson Cancer Center are poised on the brink of a new era.

• share
• favorite_border

An engineered virus tracks down and infects the most common and deadly form of brain cancer and then kills tumor cells by forcing them to devour themselves, researchers at The University of Texas M. D. Anderson Cancer Center report this week in the Journal of the National Cancer Institute.

• share
• favorite_border

A novel vaccine has significantly increased life expectancy in patients with glioblastoma multiforme (GBM), the most dangerous type of brain tumor, a researcher from The University of Texas M. D. Anderson Cancer Center is reporting at the annual meeting of the American Association of Neurological Surgeons (AANS).

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center have created a new class of hybrid virus and demonstrated its ability to find, highlight, and deliver genes to tumors in mice.

• share
• favorite_border

The University of Texas M. D. Anderson Cancer Center received the Small Business Administration's Dwight D. Eisenhower Award for Excellence in Research and Development. This marks the first time a comprehensive cancer center has been honored with the Eisenhower Award.

• share
• favorite_border

When it comes to chemotherapy treatment for women whose breast cancer has spread to their lymph nodes, the estrogen status of their tumors matters, says a team of researchers in the April 12 issue of the Journal of the American Medical Association.

• share
• favorite_border

Physicians have little to help them predict development of lung cancer in their patients - even a history of heavy smoking doesn't really help, since only a small fraction of lifetime smokers develops the cancer.

• share
• favorite_border

Breast cancer patients with HER2-positive tumors who don't respond to Herceptin (trastuzumab) may benefit from cocktail therapy that includes Herceptin along with one or more PI3K inhibiting agents, say researchers at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

In their quest to determine whether immune system surveillance guards against brain tumor development, researchers have found that allergies and asthma that stimulate inflammation may be protective, but use of antihistamines to control the inflammation could eliminate that protection.

• share
• favorite_border

Studying thousands of people, researchers have documented a 25 percent increased risk of developing one of a number of cancers in first-degree relatives of lung cancer patients who have never smoked compared to families of people who neither smoke nor have lung cancer.

• share
• favorite_border

To increase awareness of skin cancer risks and prevention strategies, renowned experts on the front lines of skin cancer research, treatment and patient care answer important questions about skin cancer risk factors, sunscreen and skin protection and skin cancer screening and treatment.

• share
• favorite_border

When Houston restaurateur Tony Masraff was diagnosed with early-stage prostate cancer, his life was packed with dancing, running marathons, playing tennis, gardening, leading a successful business and spending time with his family.

• share
• favorite_border

A potent member of a new class of drugs increases survival in some patients with myelodysplastic syndrome (MDS), and may become the new standard of therapy for this group of pre-cancer disorders.

• share
• favorite_border

For his breakthrough research in cancer therapy, John Mendelsohn, M.D., president of The University of Texas M. D. Anderson Cancer Center, has been named co-recipient of a 2006 Dan David Prize, which was announced in Paris.

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center report that they have created a way for viral and gold particles to "directly assemble" and potentially seek out and treat disease where it resides in the body.

• share
• favorite_border

The University of Texas M. D. Anderson Cancer Center has been awarded a National Cancer Institute Specialized Programs of Research Excellence (SPORE) grant for breast cancer research, the 10th such grant earned by the institution since 1996.

• share
• favorite_border

Physicians now have a tool to help monitor patients with a history of bladder cancer that is four times more effective than the conventional laboratory test in detecting the disease, according to a study.

• share
• favorite_border

As we enter the era of personalized medicine, it is time to take a fresh look at how we evaluate new medicines and treatments for cancer, according to Donald Berry, Ph.D., professor and chair of the Department of Biostatistics and Applied Mathematics at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

Can most types of cancers be prevented? It's a question that has emerged in the past 20 years, given advances in screening and early diagnosis, rapid developments in genetics and molecular biology, and progress in the treatment of early disease and in next-generation targeted therapies.

• share
• favorite_border

The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center (meeting abstract #37).

• share
• favorite_border

Early detection through screening mammography and improved adjuvant treatment have contributed almost equally to the substantial decrease in breast cancer death rates over the past 10 to 15 years, researchers conclude in an unprecedented effort to parse out the factors that have led to the decline.

• share
• favorite_border

Curcumin, the main ingredient of turmeric and the compound that gives curry its mustard-yellow color, inhibits metastasis to the lungs of mice with breast cancer, report researchers at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

An analysis of 20 years of data on the health of over 900 adults has found that long-term use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, cuts the risk for oral cancer in smokers by half.

• share
• favorite_border

How heavy a man is at the time he is diagnosed with prostate cancer, as well as his history of weight gain, appear to play significant roles in how aggressive his cancer may become, say researchers at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis have been discovered by a team of researchers. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.

• share
• favorite_border

Eating vegetables and other foods that have weak estrogen-like activity appears to reduce the risk of developing lung cancer in smokers "” as well as in non-smokers, say researchers at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center report they have discovered a potential oncogene in ovarian cancer, which is the leading cause of gynecological cancer death in U.S. women.

• share
• favorite_border

Phase I cancer studies, trials that are conducted to determine the safety and maximum dose of a new agent, are under-reported in peer-reviewed journals - a trend that could ultimately delay scientific progress and negatively affect patient care, say researchers.

• share
• favorite_border

Researchers have found that an experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma, even though prior therapy had eliminated virtually all of the B cells thought necessary to mount such a defense.

• share
• favorite_border

Women whose breast cancer was detected by screening mammography had a significantly better prognosis than those whose cancer was found another way - even if the cancer had already spread to their lymph nodes, say researchers who looked at outcomes from randomized screening studies of more than 150,000 women.

• share
• favorite_border

Texas philanthropists Red and Charline McCombs have given The University of Texas M. D. Anderson Cancer Center $30 million, the largest gift ever made to support cancer research at the institution.

• share
• favorite_border

After a lengthy re-evaluation process and the addition of new monitoring guidelines, The University of Texas M. D. Anderson Cancer Center has reactivated a lung cancer chemoprevention trial studying celecoxib, an anti-inflammatory medication also known as Celebrex(r).

• share
• favorite_border

The University of Texas M. D. Anderson Cancer Center names Patricia M. Neal the recipient of the 2005 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award, the institution's most prestigious honor in oncology nursing.

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.

• share
• favorite_border

Researchers have located a gene dubbed dead end that when mutated or lost, causes testicular tumors in mice. They say their study will likely offer future insights into the genetic causes of the disease in humans because the cancer originates from the same cell type, the primordial germ cell, in both mice and men.

• share
• favorite_border

The University of Texas M. D. Anderson Cancer Center and the Swami Vivekananda Yoga Anusandhana Samsthana (Research Foundation), Bangalore, India, today announced a research collaboration to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of cancer patients.

• share
• favorite_border

An investigational drug is producing powerful responses in patients resistant to Gleevec, the targeted therapy that helps most people diagnosed with chronic myeloid leukemia, an international research team is reporting.

• share
• favorite_border

Researchers have explained how and why different forms of ovarian cancer evolve in a discovery that could lead to earlier detection and perhaps more personalized treatment for a disease that will claim an estimated 16,210 women's lives in the United States in 2005.

• share
• favorite_border

For the first time, researchers appear to be able to use a comprehensive panel of genetic variants to predict how a patient with esophageal cancer will respond to a spectrum of cancer treatments.

• share
• favorite_border

A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

Thomas W. Burke, M.D., has been named Executive Vice President and Physician-in-Chief at M. D. Anderson Cancer Center, effective immediately. Burke has been a member of the M. D. Anderson faculty since 1988 and ad interim Senior Vice President and Chief Operating Officer for nearly a year.

• share
• favorite_border

In the largest and most comprehensive prospective study of its kind, researchers have concluded that the risk of ischemic heart disease and, ultimately, cardiac death following radiation treatment for breast cancer has steadily declined over the last quarter century.

• share
• favorite_border

Physicians now have a more dependable, less expensive tool to help detect bladder cancer earlier.

• share
• favorite_border

In a new study, researchers present a "cautionary tale" about what may go wrong when using the fledgling science of proteomics to devise a diagnostic test for cancer.

• share
• favorite_border

The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study.

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center have found that women with a common thyroid gland disorder appear to have a reduced chance of developing invasive breast cancer, according to a study.

• share
• favorite_border

Based on successful animal studies, a novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some human breast cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

Women with a rare type of advanced breast cancer who do not benefit from primary (pre-surgical) chemotherapy still have been found to do better in the long run than patients with a more common advanced breast cancer who do respond to chemotherapy.